COVID-19 vaccination in Thailand

In November 2020, the authorities ordered 26 million doses of vaccine from AstraZeneca, which reported 70% overall efficacy.

[5] Siam Bioscience, a company owned by King Vajiralongkorn, will received technological transfer for co-investment.

[6] The authorities also imported 2 million doses of vaccine from Sinovac, a Chinese company which Thai conglomerate Charoen Pokphand invested in,[7] during February to April 2021.

[8] Likewise, the Thai government also stepped up its attempt to produce its homegrown vaccines amidst criticism,[9] with "ChulaCov19" and set to begin trials in May 2021.

[13] Meanwhile, the government's prior commitment to secure 61 million doses of AstraZeneca vaccine became doubted after a leaked document showed that the company would deliver no more than 60 percent of the number planned per month.